Detection and Characterization of Influenza B Virus with Reduced Neuraminidase Susceptibility in a Stem Cell Transplant Recipient-Reference-Cited by-同舟云学术

Detection and Characterization of Influenza B Virus with Reduced Neuraminidase Susceptibility in a Stem Cell Transplant Recipient

Published:2019-11-18 Issue: Volume: Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Kodiyanplakkal Rosy Priya L¹,Laplante Jennifer M²,Westblade Lars F¹³,van Besien Koen¹,Salvatore Mirella¹,St. George Kirsten²

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA

2. Laboratory of Viral Diseases, Wadsworth Center, New York State Department of Health, Albany, NY, USA

3. Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA

Abstract

Abstract Antiviral-resistant influenza viruses in the clinical environment, especially type B, are rarely reported. A stem cell transplant recipient remained influenza B positive for two months, despite repeated antiviral treatments. Laboratory tests demonstrated the evolution and persistence of neuraminidase inhibitor-resistant influenza B virus with a substitution at codon 119.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofz493/30927440/ofz493.pdf

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical updates in clinical antiviral resistance testing;Journal of Clinical Microbiology;2024-08-14

2. Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir;Transplant Infectious Disease;2020-06-10

3. Antithymocyte-globulin/oseltamivir/sirolimus;Reactions Weekly;2020-03